We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGEN icon
12326
PUT
Precigen
PGEN
$2.51B
$83K ﹤0.01%
39,200
-6,500
-14% -$15.8K
SLND.WS icon
12327
Southland Holdings Warrants
SLND.WS
$83K ﹤0.01%
225,000
-165,425
-42% -$71.6K
WATT icon
12328
CALL
Energous
WATT
$102M
$83K ﹤0.01%
115
-170
-60% -$118K
XTKG
12329
DELISTED
X3 Holdings Co., Ltd. Class A Ordinary Shares
XTKG
0
DVLT
12330
Datavault AI
DVLT
$256M
$83K ﹤0.01%
5
-2
-29% -$36.7K
BIOSW
12331
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$83K ﹤0.01%
+375,000
New +$97.4K
FZT.WS
12332
DELISTED
FAST Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FZT.WS
$83K ﹤0.01%
249,999
-125,000
-33% -$66.8K
IQMDW
12333
DELISTED
Intelligent Medicine Acquisition Corp. Warrant
IQMDW
$83K ﹤0.01%
300,000
IIIIW
12334
DELISTED
INSU Acquisition Corp. III Warrant
IIIIW
$83K ﹤0.01%
416,676
+10
+0% +$4
EQOS
12335
CALL
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$83K ﹤0.01%
36,900
+15,200
+70% +$28.9K
XELA
12336
CALL
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$83K ﹤0.01%
50
+4
+9% +$10K
SRGA
12337
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$83K ﹤0.01%
9,188
-2,463
-21% -$37.4K
CTIC
12338
PUT
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$83K ﹤0.01%
17,700
-6,600
-27% -$19.7K
QIWI
12339
DELISTED
QIWI PLC
QIWI
$83K ﹤0.01%
40,413
-93,243
-70% -$690K
HROW icon
12340
PUT
Harrow
HROW
$1.52B
$82K ﹤0.01%
+12,000
New +$92.6K
AIXC
12341
AIxCrypto Holdings Inc
AIXC
$16M
$82K ﹤0.01%
+249
New +$97.2K
FREE
12342
CALL
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$82K ﹤0.01%
11,400
-3,100
-21% -$27.8K
NFYS.WS
12343
DELISTED
Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFYS.WS
$82K ﹤0.01%
295,292
+942
+0.3% +$373
SCTL
12344
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$82K ﹤0.01%
45,541
-25,223
-36% -$43.7K
EQRX
12345
PUT
DELISTED
EQRx, Inc. Common Stock
EQRX
$82K ﹤0.01%
19,900
-22,700
-53% -$98.8K
ATNX
12346
DELISTED
Athenex, Inc. Common Stock
ATNX
$82K ﹤0.01%
4,978
-2,048
-29% -$40.1K
VOLT
12347
CALL
DELISTED
Volt Information Sciences, Inc.
VOLT
$82K ﹤0.01%
13,700
-9,100
-40% -$34.6K
BCLI
12348
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$81K ﹤0.01%
+1,608
New +$78.9K
GNPX icon
12349
Genprex
GNPX
$2.12M
$81K ﹤0.01%
+1
New +$97.5K
SCYX icon
12350
CALL
SCYNEXIS
SCYX
$51.2M
$81K ﹤0.01%
2,600
-1,163
-31% -$44.5K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.